3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.
Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R, Geschwind JF.
Ganapathy-Kanniappan S, et al. Among authors: kunjithapatham r.
Curr Pharm Biotechnol. 2010 Aug;11(5):510-7. doi: 10.2174/138920110791591427.
Curr Pharm Biotechnol. 2010.
PMID: 20420565
Review.